Biolase Inc (BIOL)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
DENTAL EQUIPMENT & SUPPLIES
CEO:
Harold C. Flynn
Employees:
190
4 CROMWELL, IRVINE, CA 92618
949-361-1200

BIOLASE, Inc. is a medical technology company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners, in-office, chair-side milling machines and three-dimensional printers. The company offers two categories of laser system products: Waterlase systems and Diode systems. Its flagship product category, the Waterlase system, uses a patented combination of water and laser to perform most procedures, performs using dental drills, scalpels and other traditional dental instruments for cutting soft and hard tissue. It also offers a family of Diode laser system products, including its ezlase soft tissue diode laser, to perform soft tissue and cosmetic procedures, including tooth whitening. The company also manufactures and sells accessories and disposables for its laser systems, such as hand pieces, laser tips and tooth whitening gel. BIOLASE was founded in 1987 and is headquartered in Irvine, CA.

Data derived from most recent annual or quarterly report
Market Cap 61.618 Million Shares Outstanding153.28 Million Avg 30-day Volume 4.029 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.06
Price to Revenue3.2554 Debt to Equity0.0 EBITDA-10.588 Million
Price to Book Value3.166 Operating Margin-57.4143 Enterprise Value67.929 Million
Current Ratio4.351 EPS Growth0.404 Quick Ratio3.216
1 Yr BETA 1.7066 52-week High/Low 1.51 / 0.37 Profit Margin-42.4928
Operating Cash Flow Growth12.8995 Altman Z-Score-2.9144 Free Cash Flow to Firm 148 Thousand
View SEC Filings from BIOL instead.

View recent insider trading info

Funds Holding BIOL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BIOL BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

70 Thousand total shares from 1 transactions

Open Market Sells (S)

11 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LORD JONATHAN T MD

  • Director
633,096 2021-12-15 2

BEAVER JOHN R PRESIDENT & CEO

  • Officer
  • Director
621,530 2021-11-30 6

SUMMERHAYS CAROL GOMEZ DDS

  • Director
0 2021-08-12 2

SOMERMAN MARTHA J. DDS, PHD

  • Director
98,955 2021-08-12 2

OLOUGHLIN KATHLEEN T

  • Director
0 2021-08-12 2

ROPER JESS

  • Director
249,337 2021-06-11 1

LANMAN RICHARD B.

  • Director
242,603 2021-06-11 1

SATO GARRETT

  • Director
248,888 2021-06-11 1

WAGNER ELAINE C

  • Director
242,603 2021-06-11 1

DITOLLA MICHAEL

  • Director
215,003 2021-06-11 1

NORBE TODD PRESIDENT AND CEO

  • Officer
  • Director
0 2020-08-06 0

FEINBERG LARRY N

ORACLE PARTNERS LP

  • 10% Owner
No longer subject to file 2020-06-08 0

SCHULER JACK W

759,820 2020-02-11 0

TALEVICH JAMES R

  • Director
20,374 2018-05-11 0

FLYNN HAROLD C JR. PRESIDENT AND CEO

  • Officer
  • Director
228,690 2017-12-05 0

FEINBERG LARRY N

ORACLE PARTNERS LP

ORACLE ASSOCIATES LLC

ORACLE INVESTMENT MANAGEMENT INC

  • 10% Owner
30,866,265 2017-12-04 0

FEINBERG LARRY N

ORACLE PARTNERS LP

ORACLE ASSOCIATES LLC

  • 10% Owner
21,465,461 2017-06-30 0

CLARK PAUL N

  • Director
1,629,007 2017-06-30 0

MOLL FREDERIC H

  • Director
251,317 2017-06-30 0

NELSON MARK JOSEPH SVP & CHIEF FINANCIAL OFFICER

  • Officer
9,538 2017-04-18 0

SCHULER JACK W

JACK W. SCHULER LIVING TRUST

10,238,756 2016-12-29 0

DREYER DAVID C SVP / CHIEF FINANCIAL OFFICER

  • Officer
123,000 2016-07-01 0

JACK W. SCHULER LIVING TRUST

  • 10% Owner
5,885,603 2015-11-23 0

FEINBERG LARRY N

  • 10% Owner
10,529,525 2015-11-11 0

NUGENT JEFFREY M CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
118,850 2014-11-03 0

SCHULER FAMILY FOUNDATION

  • 10% Owner
0 2014-11-03 0

ARROW ALEXANDER K. PRESIDENT AND COO

  • Officer
110,387 2014-07-22 0

FURRY FREDERICK D. CHIEF FINANCIAL OFFICER

  • Officer
18,020 2014-07-22 0

LOW SAMUEL BERNARD

  • Director
0 2013-12-10 0

ENRIGHT ERIN S.

  • Director
0 2013-06-07 0

LICHTWARDT GREGORY

  • Director
0 2013-06-06 0

NEMOY NORMAN J.

  • Director
0 2013-06-06 0

PIGNATELLI FEDERICO CHAIRMAN AND CEO

  • Officer
  • Director
0 2012-11-08 0

MULDER DAVID M

  • FORMER DIRECTOR AND CEO
No longer subject to file 2010-09-30 0

LAIRD NEIL J

  • FORMER DIRECTOR
No longer subject to file 2010-05-27 0

WALLER GREGORY D

  • Director
0 2010-05-05 0

DARBELOFF GEORGE V

  • Director
0 2010-05-05 0

ANDERTON ROBERT M

  • Director
0 2010-05-05 0

LARGENT JAMES R

  • Director
0 2010-05-05 0

DURRIE DANIEL S

  • Director
58,736 2009-08-25 0

CAPALLO FRED INTERIM CHIEF FINANCIAL OFF.

  • Officer
No longer subject to file 2009-08-25 0

SCOTT BRETT L CHIEF FINANCIAL OFFICER

  • Officer
0 2009-07-14 0

ST PHILIP JAKE CEO

  • Officer
  • Director
40,000 2008-05-30 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

LORD JONATHAN T MD - Director

2021-12-16 18:38:52 -0500 2021-12-15 S 11,038 $0.38 d 633,096 direct -3.75 6.25 6.25 6 -3.75 2

BEAVER JOHN R - Director - Officer PRESIDENT & CEO

2021-12-02 17:27:13 -0500 2021-11-30 P 70,000 $0.45 a 621,530 direct -2.6634 -2.9056 5.0847 4 -2.9056 6

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BIOLASE INC BIOL 2022-01-17 22:15:04 UTC -1.0063 1.0763 3800000
BIOLASE INC BIOL 2022-01-17 21:45:03 UTC -1.0063 1.0763 3800000
BIOLASE INC BIOL 2022-01-17 21:15:03 UTC -1.0063 1.0763 3800000
BIOLASE INC BIOL 2022-01-17 20:45:03 UTC -1.0063 1.0763 3800000
BIOLASE INC BIOL 2022-01-17 20:15:04 UTC -1.0063 1.0763 3800000
BIOLASE INC BIOL 2022-01-17 19:45:03 UTC -1.0063 1.0763 3800000
BIOLASE INC BIOL 2022-01-17 19:15:03 UTC -1.0063 1.0763 3800000
BIOLASE INC BIOL 2022-01-17 18:45:03 UTC -1.0063 1.0763 3800000
BIOLASE INC BIOL 2022-01-17 18:15:03 UTC -1.0063 1.0763 3800000
BIOLASE INC BIOL 2022-01-17 17:45:03 UTC -1.0063 1.0763 3800000
BIOLASE INC BIOL 2022-01-17 17:15:03 UTC -1.0063 1.0763 3800000
BIOLASE INC BIOL 2022-01-17 16:45:03 UTC -1.0063 1.0763 3800000
BIOLASE INC BIOL 2022-01-17 16:15:04 UTC -1.0063 1.0763 3800000
BIOLASE INC BIOL 2022-01-17 15:45:03 UTC -1.0063 1.0763 3800000
BIOLASE INC BIOL 2022-01-17 15:15:03 UTC -1.0063 1.0763 3800000
BIOLASE INC BIOL 2022-01-17 14:45:03 UTC -0.9992 1.0692 3800000
BIOLASE INC BIOL 2022-01-17 14:15:03 UTC -0.9992 1.0692 3800000
BIOLASE INC BIOL 2022-01-17 13:45:03 UTC -0.9992 1.0692 3800000
BIOLASE INC BIOL 2022-01-17 13:15:03 UTC -0.9992 1.0692 3800000
BIOLASE INC BIOL 2022-01-17 12:45:03 UTC -0.9992 1.0692 3800000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments